Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTs for Schistosomiasis in Malaria Co-infection
NCT04264130Phase 2Completed
- Sponsor
- Centre de Recherches Médicales de Lambaréné
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artesunate + pyronaridine, artemether + lumefantrine in urinary schistosomiasis, sponsored by Centre de Recherches Médicales de Lambaréné. Started Jul 2018; status: completed.
02
Drugs
artesunate + pyronaridineartemether + lumefantrine
03
Conditions
urinary schistosomiasis
Beyond the preview
Go deeper on NCT04264130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04264130.